Silver-Russell Syndrome in 2025: Is It Still a Distinct Diagnostic Entity?
- 2 January 2025
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
Abstract
Eloïse Giabicani, Amélie Perrière, Irène Netchine; Silver-Russell Syndrome in 2025: Is It Still a Distinct Diagnostic Entity?, The Journal of Clinical EndoKeywords
This publication has 7 references indexed in Scilit:
- Distinguishing Genetic Alterations Versus (Epi)Mutations in Silver–Russell Syndrome and Focus on the IGF1R GeneThe Journal of Clinical Endocrinology & Metabolism, 2024
- A Comprehensive Cohort Analysis Comparing Growth and GH Therapy Response in IGF1R Mutation Carriers and SGA ChildrenThe Journal of Clinical Endocrinology & Metabolism, 2019
- Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disordersScience Advances, 2019
- Genetic disruption of the oncogenic HMGA2–PLAG1–IGF2 pathway causes fetal growth restrictionGenetics in Medicine, 2018
- Diagnosis and management of Silver–Russell syndrome: first international consensus statementNature Reviews Endocrinology, 2016
- A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndromeJournal of Medical Genetics, 2015
- SYNDROME OF CONGENITAL HEMIHYPERTROPHY, SHORTNESS OF STATURE, AND ELEVATED URINARY GONADOTROPINSPediatrics, 1953